Pure Global AI
NCT06037499Enrolling by invitation

System Accuracy of 14 Blood Glucose Monitoring Systems

Leistungsbewertungsprüfung Der Systemgenauigkeit, Von 14 Blutglukose Monitoring Systemen in Anlehnung an ISO 15197:2015
Institut fur Diabetes Karlsburg GmbHClinicalTrials.govdiagnostic test
Verified
Study focus
Disease/Condition
Diabetes
Drug/Device/Intervention
Glucometer Test
Study type
Interventional
Intervention type
diagnostic test
Sponsor & location
Primary sponsor
Institut fur Diabetes Karlsburg GmbH
Location
Karlsburg, Germany
Timeline & enrollment
Phase
N/A
Start date
Mar 03, 2023
End date
Mar 01, 2025
Enrollment
500 participants
Primary outcome

Blood glucose measurement using BGMS

Summary

The system accuracy of 14 blood glucose monitoring systems is to be evaluated randomly in
 accordance with DIN EN ISO 15197:2015 over thr courese of 24 months

ICD-10 classifications
Diabetes mellitusUnspecified diabetes mellitusOther specified diabetes mellitusUnspecified diabetes mellitus without complicationsOther specified diabetes mellitus without complications
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06037499
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06037499 through Pure Global AI's free database. This phase not specified trial is sponsored by Institut fur Diabetes Karlsburg GmbH and is currently Enrolling by invitation. The study focuses on Diabetes. Target enrollment is 500 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.